Massachusetts Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361K | Buy |
2,874
+115
| +4% | +$14.4K | 0.2% | 78 |
|
|
2025
Q1 | $378K | Buy |
2,759
+19
| +0.7% | +$2.6K | 0.26% | 70 |
|
|
2024
Q4 | $419K | Sell |
2,740
-135
| -5% | -$20.6K | 0.26% | 77 |
|
|
2024
Q3 | $557K | Sell |
2,875
-25
| -0.9% | -$4.85K | 0.35% | 72 |
|
|
2024
Q2 | $672K | Sell |
2,900
-50
| -2% | -$11.6K | 0.45% | 70 |
|
|
2024
Q1 | $636K | Sell |
2,950
-300
| -9% | -$64.7K | 0.45% | 69 |
|
|
2023
Q4 | $841K | Buy |
3,250
+50
| +2% | +$12.9K | 0.68% | 56 |
|
|
2023
Q3 | $822K | Sell |
3,200
-50
| -2% | -$12.9K | 0.76% | 54 |
|
|
2023
Q2 | $926K | Buy |
3,250
+175
| +6% | +$49.8K | 0.89% | 50 |
|
|
2023
Q1 | $855K | Sell |
3,075
-325
| -10% | -$90.4K | 0.88% | 48 |
|
|
2022
Q4 | $989K | Buy |
+3,400
| New | +$989K | 0.96% | 46 |
|